Director, Genitourinary (GU) Oncology

Rochester, New York (US)
Competitive salary and benefits
Aug 21, 2019
Sep 20, 2019
Full Time

Director, Genitourinary (GU) Oncology

The Organization: The University of Rochester Division of Hematology-Oncology and Wilmot Cancer Institute (WCI) are the major resource for comprehensive cancer care, research, education and community outreach in central New York state. WCI, a component of Strong Memorial Hospital, offers patients and their families comprehensive services, including one of Upstate New York’s largest blood and marrow transplant programs, and the Rochester area’s only ACOS-accredited breast cancer center. WCI is home to the region’s first survivorship clinic and offers clinical trials of new therapies and options that may not be available anywhere else Upstate. WCI employs more than 130 physicians providing oncology care, more than 400 registered nurses and advanced practice providers, and a team of scientists who investigate many aspects of cancer, with an emphasis on how best to provide precision cancer care.

The Opportunity: The hematology-oncology division at WCI|UR Medicine is recruiting an experienced clinical investigator to lead an expanding academic and clinical program in genitourinary oncology. This multidisciplinary program consists of surgical, oncologic, radiation, imaging and pathology subspecialists. The genitourinary medical oncology program leader must be committed to clinical excellence, research and teaching. The selected candidate will be expected to develop the research program by expanding the clinical trial portfolio and bridge the existing comprehensive clinical program with the strong research environment and supporting structures within WCI. This position will report directly to the associate chief, solid tumors, for hematology/oncology.

The Candidate: The successful candidate must have a Doctor of Medicine degree (MD) or MD/PhD. Candidates must be board certified in medical oncology. Demonstrated leadership and administrative experience in an academic medical center or a genitourinary oncology program in a designated center is required. A strong history or clinical research funding in urinary system cancer/medical oncology is also required.

The Community: Rochester consistently receives high rankings nationally as a “most livable city” for overall quality of life and as one of the very best places to raise a family. Rochester enjoys economic stability and a level of arts, culture, sports and dining comparable to that of many larger cities. Please visit the following websites for additional information about Rochester:, or

University of Rochester/Wilmot Cancer Institute is an equal opportunity/affirmative action employer.

Confidential inquiries, nominations and referrals should be submitted to:

Dennis J. Kain, FACHE
Senior Vice President

Wendy Siegel
Senior Consultant